809 related articles for article (PubMed ID: 32675392)
21. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
Ji Y; Wang M; Li X; Cui F
Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
[TBL] [Abstract][Full Text] [Related]
22. Deletion of
Meng Q; Wang L; Lv Y; Wu J; Shi W
Cancer Biother Radiopharm; 2021 Feb; 36(1):23-35. PubMed ID: 32319789
[No Abstract] [Full Text] [Related]
23. Long Noncoding RNA XIST Contributes to Cervical Cancer Development Through Targeting miR-889-3p/SIX1 Axis.
Liu X; Xie S; Zhang J; Kang Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):640-649. PubMed ID: 32191528
[No Abstract] [Full Text] [Related]
24. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
Liu Y; Wei G; Ma Q; Han Y
Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
[TBL] [Abstract][Full Text] [Related]
25. LncRNA NEAT1 facilitates the progression of sepsis through up-regulating TSP-1 via sponging miR-370-3p.
Wu XY; Fang Y; Zheng FX; Zhang YZ; Li QL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):333-344. PubMed ID: 31957847
[TBL] [Abstract][Full Text] [Related]
26. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
Pang L; Cheng Y; Zou S; Song J
Thorac Cancer; 2020 Feb; 11(2):264-276. PubMed ID: 31793741
[TBL] [Abstract][Full Text] [Related]
28. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Potential of Long Noncoding RNA NEAT1 in Colorectal Cancer.
Cheng H; Malhotra A
J Environ Pathol Toxicol Oncol; 2020; 39(2):101-111. PubMed ID: 32749120
[TBL] [Abstract][Full Text] [Related]
30. LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p.
Yu HM; Wang C; Yuan Z; Chen GL; Ye T; Yang BW
Cell Prolif; 2019 Jan; 52(1):e12526. PubMed ID: 30407674
[TBL] [Abstract][Full Text] [Related]
31. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression.
Zhao D; Zhang Y; Wang N; Yu N
Cancer Biomark; 2017 Sep; 20(3):247-254. PubMed ID: 28946559
[TBL] [Abstract][Full Text] [Related]
32. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
Tan H; Zhao L
J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
[TBL] [Abstract][Full Text] [Related]
33. The LncRNA NEAT1 Accelerates Lung Adenocarcinoma Deterioration and Binds to Mir-193a-3p as a Competitive Endogenous RNA.
Xiong DD; Li ZY; Liang L; He RQ; Ma FC; Luo DZ; Hu XH; Chen G
Cell Physiol Biochem; 2018; 48(3):905-918. PubMed ID: 30036873
[TBL] [Abstract][Full Text] [Related]
34. LncRNA NEAT1 regulated cell proliferation, invasion, migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer.
Chen LM; Niu YD; Xiao M; Li XJ; Lin H
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4810-4821. PubMed ID: 32432744
[TBL] [Abstract][Full Text] [Related]
35. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells.
Wang C; Xie XX; Li WJ; Jiang DQ
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195
[TBL] [Abstract][Full Text] [Related]
36. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis.
Zhang B; Sun YF; Zhang XM; Jiang N; Chen Q
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4940-4953. PubMed ID: 32432757
[TBL] [Abstract][Full Text] [Related]
37. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Nuclear Enriched Autosomal Transcript 1 Facilitates Cell Proliferation, Migration Invasion, and Suppresses Apoptosis in Endometrial Cancer by Targeting MicroRNA-202-3p/T Cell Immunoglobulin and Mucin Domain 4 Axis.
Xu C; Zhai J; Fu Y
Cancer Biother Radiopharm; 2022 Nov; 37(9):815-823. PubMed ID: 32882142
[No Abstract] [Full Text] [Related]
40. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
Sun T; Song Y; Yu H; Luo X
Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
